Viral Antigens/Virale Antigene. SARS Proteins/SARS Proteine
|
|
|
- Erik Garrison
- 8 years ago
- Views:
Transcription
1 SARS Proteins/SARS Proteine SARS S(N) Recombinant SARS Associated Spike Mosaic S(N) CB μg CB μg CB μg SARS S(M) Recombinant SARS Associated Spike Mosaic S(M) CB μg CB μg CB μg SARS S(C) Recombinant SARS Associated Spike Mosaic S(C) CB μg CB μg CB μg SARS Recombinant SARS Associated Coronavirus Nucleocaspid CB μg Nucleocaspid ( ) CB μg CB μg SARS Recombinant SARS Associated Coronavirus Nucleocaspid (1-49) CB μg Nucleocaspid CB μg CB μg SARS Recombinant SARS Associated Coronavirus Nucleocaspid CB μg Nucleocaspid (1-49, ) CB μg CB μg SARS Recombinant SARS-CoV Nucleocapsid (1-422) CB μg Nucleocaspid CB μg CB μg SARS Matrix Recombinant SARS Associated Coronavirus Matrix CB μg CB μg CB μg SARS Envelope Recombinant SARS Associated Coronavirus Envelo CB μg CB μg CB μg Malaria Proteins/Malariaproteine Malaria HSP Recombinant Malaria Protein HSP CB μg CB μg CB μg Malaria Mosaic Recombinant Malaria Cs Mosaic CB μg CB μg CB μg Borrelia Proteins/Borrelienproteine Borrelia p41 Recombinant Borrelia p41 CB μg CB μg CB μg Chagas Proteins/Chagasproteine Chagas TcF Recombinant Chagas TcF Antigen CB μg CB μg CB μg.55
2 Herpes Simplex Virus/Herpes Simplex Virus HSV-1 gd Recombinant Herpes Simplex Virus-1 gd CB μg CB μg CB μg HSV-1 gg Recombinant Herpes Simplex Virus-1 gg CB μg CB μg CB μg HSV-2 gd Recombinant Herpes Simplex Virus-2 gd CB μg CB μg CB μg rhsv-2 gg Recombinant Herpes Simplex Virus-2 gg CB μg CB μg CB μg HSV-8 Mosaic Recombinant Herpes Simplex Virus-8 Mosaic CB μg CB μg CB μg Chlamydia Trachomatis/Chlamydia Trachomatis Chlamydia W2 Recombinant Chlamydia Trachomatis W2 CB μg CB μg CB μg Chlamydia W4 Recombinant Chlamydia Trachomatis W4 CB μg CB μg CB μg Chlamydia W5 Recombinant Chlamydia Trachomatis W5 CB μg CB μg CB μg Chlamydia Recombinant Chlamydia Trachomatis W4-W5 CB μg W4-5 CB μg CB μg Chlamydia Recombinant Chlamydia Trachomatis W5-W CB μg W5- CB μg CB μg Chlamydia Recombinant Chlamydia Trachomatis W3-W CB μg W3- CB μg CB μg Chlamydia Recombinant Chlamydia Trachomatis PGP3-D CB μg PGP-3D CB μg CB μg Chlamydia Recombinant Chlamydia Trachomatis HSP70 (42-503) CB μg HSP70 CB μg CB μg Chlamydia Recombinant Chlamydia Trachomatis HSP70 (549-0) CB μg HSP70 CB μg CB μg.5
3 Hepatitis C Virus/Hepatitis C Virus HCV Recombinant Hepatitis C Virus Nucleocapsid (core) Genotype-1 CB μg Genotype-1 CB μg CB μg HCV Recombinant Hepatitis C Virus Nucleocapsid (core) Genotype-1a CB μg Genotype-1a CB μg CB μg HCV Recombinant Hepatitis C Virus Nucleocapsid (core) Genotype-1b CB μg Genotype-1b CB μg CB μg HCV Recombinant Hepatitis C Virus Nucleocapsid (core) Genotype-2a CB μg Genotype-2a CB μg CB μg HCV Recombinant Hepatitis C Virus Nucleocapsid (core) Genotype-2b CB μg Genotype-2b CB μg CB μg HCV Recombinant Hepatitis C Virus Nucleocapsid (core) Genotype-3a CB μg Genotype-3a CB μg CB μg HCV Recombinant Hepatitis C Virus Nucleocapsid (core) Genotype-3b CB μg Genotype-3b CB μg CB μg HCV Recombinant Hepatitis C Virus Nucleocapsid (core) Genotype-4 CB μg Genotype-4 CB μg CB μg HCV Recombinant Hepatitis C Virus Nucleocapsid (core) Genotype-5 CB μg Genotype-5 CB μg CB μg HCV Recombinant Hepatitis C Virus Nucleocapsid (core) Genotype-a CB μg Genotype-a CB μg CB μg HCV Recombinant Hepatitis C Virus Nucleocapsid (core) Genotype-3/10 CB μg Genotype-3/10 CB μg CB μg HCV Recombinant Hepatitis C Virus Nucleocapsid (core), Biotin Labeled CB μg Core-Biotin CB μg CB μg HCV Core-HRP Recombinant Hepatitis C Virus Nucleocapsid (core), CB μg Horseradish Peroxidase Labled CB μg CB μg HCV ( ) Recombinant Hepatitis C Virus Nucleocapsid (core) ( ) CB μg CB μg CB μg HCV Core-24 Recombinant Hepatitis C Virus Nucleocapsid (core) 24 CB μg CB μg CB μg HCV Combined Recombinant Hepatitis C Virus Combined CB μg CB μg CB μg HCV 22kDa Recombinant Hepatitis C Virus Nucleocapsid (core) 22kDa CB μg CB μg CB μg HCV 22kDa Recombinant Hepatitis C Virus Nucleocapsid (core) 22kDa, Biotin CB μg Biotin CB μg CB μg HCV 22kDa Recombinant Hepatitis C Virus Nucleocapsid (core) 22kDa, CB μg Fluorecein Fluorecein Labeled CB μg CB μg.57
4 Hepatitis C Virus/Hepatitis C Virus HCV 22kDa Recombinant Hepatitis C Virus Nucleocapsid (core) 22kDa, CB μg Rhodamine Rhodamine Labeled CB μg CB μg HCV NS3 Recombinant Hepatitis C Virus NS3 Genotype-1a ( ) CB μg Genotype-1a CB μg CB μg HCV NS3 Recombinant Hepatitis C Virus NS3 Genotype-1a ( ) CB μg Genotype-1a CB μg CB μg HCV NS3 Recombinant Hepatitis C Virus NS3 Genotype-1b ( ) CB μg Genotype-1b CB μg CB μg HCV NS3 Recombinant Hepatitis C Virus NS3 Genotype-1b CB μg Genotype-1b CB μg CB μg HCV NS3 Recombinant Hepatitis C Virus NS3 Genotype-1b ( ) CB μg Genotype-1b CB μg CB μg HCV NS3 Recombinant Hepatitis C Virus NS3 Genotype-1c CB μg Genotype-1c CB μg CB μg HCV NS3 Recombinant Hepatitis C Virus NS3 Genotype-2b ( ) CB μg Genotype-2b CB μg CB μg HCV NS3 Recombinant Hepatitis C Virus NS3 Genotype-2b ( ) CB μg Genotype-2b CB μg CB μg HCV NS3 Recombinant Hepatitis C Virus NS3 Genotype-2c ( ) CB μg Genotype-2c CB μg CB μg HCV NS3 Recombinant Hepatitis C Virus NS3 Genotype-2c ( ) CB μg Genotype-2c CB μg CB μg HCV NS3 Recombinant Hepatitis C Virus NS3 Genotype-3 ( ) CB μg Genotype-3 CB μg CB μg HCV NS3 Recombinant Hepatitis C Virus NS3 Genotype-4 ( ) CB μg Genotype-4 CB μg CB μg HCV NS3 Recombinant Hepatitis C Virus NS3 Genotype-5 ( ) CB μg Genotype-5 CB μg CB μg HCV NS3 Recombinant Hepatitis C Virus NS3 Genotype-5 ( ) CB μg Genotype-5 CB μg CB μg HCV NS3 Recombinant Hepatitis C Virus NS3 Genotype-5a CB μg Genotype-5a CB μg CB μg HCV NS3 Recombinant Hepatitis C Virus NS3 Genotype-a ( ) CB μg Genotype-a CB μg CB μg HCV NS3 Recombinant Hepatitis C Virus NS3 Genotype- ( ) CB μg Genotype- CB μg CB μg HCV NS3 Recombinant Hepatitis C Virus NS3 ( ) CB μg CB μg CB μg 4.58
5 Hepatitis C Virus/Hepatitis C Virus HCV NS3-Biotin Recombinant Hepatitis C Virus NS3, Biotin Labeled CB μg CB μg CB μg HCV NS3-HRP Recombinant Hepatitis C Virus NS3, Horseradish Peroxidase CB μg Labeled CB μg CB μg HCV NS4 Recombinant Hepatitis C Virus NS4 Mosaic CB μg Mosaic CB μg CB μg HCV NS4 Recombinant Hepatitis C Virus NS4 Mosaic Genotype-1 CB μg Genotype-1 CB μg CB μg HCV NS4 Recombinant Hepatitis C Virus NS4 Mosaic Genotype-2 CB μg Genotype-2 CB μg CB μg HCV NS4 Recombinant Hepatitis C Virus NS4 Mosaic Genotype-3 CB μg Genotype-3 CB μg CB μg HCV NS4 Recombinant Hepatitis C Virus NS4 Mosaic Genotype-5 CB μg Genotype-5 CB μg CB μg HCV NS4 Recombinant Hepatitis C Virus NS4 CB μg CB μg CB μg HCV NS4 HRP Recombinant Hepatitis C Virus NS4, Horseradish Peroxidase CB μg Labeled CB μg CB μg HCV NS4 a+b Recombinant Hepatitis C Virus NS4 a+b CB μg CB μg CB μg HCV NS4 a+b Recombinant Hepatitis C Virus NS4 a+b, Fluorecein Labeled CB μg Fluorecein CB μg CB μg HCV NS4 a+b Recombinant Hepatitis C Virus NS4 a+b, Rhodamine Labeled CB μg Rhodamine CB μg CB μg HCV NS4 a+b Recombinant Hepatitis C Virus NS4 a+b, Biotin Labeled CB μg Biotin CB μg CB μg HCV NS5 Recombinant Hepatitis C Virus NS5 Genotype-1 CB μg Genotype-1 CB μg CB μg HCV NS5 Recombinant Hepatitis C Virus NS5 Genotype-1a ( ) CB μg Genotype-1a CB μg CB μg HCV NS5 Recombinant Hepatitis C Virus NS5 Genotype-1a CB μg Genotype-1a CB μg CB μg HCV NS5 Recombinant Hepatitis C Virus NS5 Genotype-1b CB μg Genotype-1b CB μg CB μg HCV NS5 Recombinant Hepatitis C Virus NS5 Genotype-2 CB μg Genotype-2 CB μg CB μg HCV NS5 Recombinant Hepatitis C Virus NS5 Genotype-2a CB μg Genotype-2a CB μg CB μg.59
6 Hepatitis C Virus/Hepatitis C Virus HCV NS5 Recombinant Hepatitis C Virus NS5 Genotype-2b CB μg Genotype-2b CB μg CB μg HCV NS5 Recombinant Hepatitis C Virus NS5 Genotype-3 CB μg Genotype-3 CB μg CB μg HCV NS5 Recombinant Hepatitis C Virus NS5 Genotype-3a CB μg Genotype-3a CB μg CB μg HCV NS5 Recombinant Hepatitis C Virus NS5 Genotype-3b CB μg Genotype-3b CB μg CB μg HCV NS5 Recombinant Hepatitis C Virus NS5 Genotype-4 CB μg Genotype-4 CB μg CB μg HCV NS5 Recombinant Hepatitis C Virus NS5 Genotype-5 CB μg Genotype-5 CB μg CB μg HCV NS5 Recombinant Hepatitis C Virus NS5 Genotype- CB μg Genotype- CB μg CB μg HCV NS5 Recombinant Hepatitis C Virus NS5 Genotype-a CB μg Genotype-a CB μg CB μg HCV NS5 Recombinant Hepatitis C Virus NS5 CB μg CB μg CB μg HCV NS5 Recombinant Hepatitis C Virus NS5, Biotin Labled CB μg Biotin CB μg CB μg HCVNS5 HRP Recombinant Hepatitis C Virus NS5, Horseradish Peroxidase CB μg Labled CB μg CB μg.0
7 Hepatitis A Virus/Hepatitis A Virus HAV VP1 Recombinant Hepatitis A Virus VP1 CB μg CB μg CB μg HAV VP1-P2A Recombinant Hepatitis A Virus VP1-P2A ( ) CB μg CB μg CB μg HAV VP1-P2A Recombinant Hepatitis A Virus VP1-P2A (9-782) CB μg CB μg CB μg HAV P2C Recombinant Hepatitis A Virus P2C CB μg CB μg CB μg HAV P2C-P3B Recombinant Hepatitis A Virus P2C-P3B CB μg CB μg CB μg HAV P2C-P3A Recombinant Hepatitis A Virus P2C-P3A CB μg CB μg CB μg HAV P3C Recombinant Hepatitis A Virus P3C CB μg CB μg CB μg HAV VP3 Recombinant Hepatitis A Virus VP3 CB μg CB μg CB μg HAV VP4-VP2 Recombinant Hepatitis A Virus VP4-VP2 CB μg CB μg CB μg Hepatitis B Virus/Hepatitis B Virus HBcAg Recombinant Hepatitis B Virus Core (1-18) CB μg CB μg CB μg HBcAg Recombinant Hepatitis B Virus Core (1-183) CB μg CB μg CB μg HBcAg Delta Recombinant Hepatitis B Virus Core Delta CB μg CB μg CB μg HBV X Recombinant Hepatitis B Virus x CB μg CB μg CB μg HBV HBe Recombinant Hepatitis B Virus HBe CB μg CB μg CB μg Hepatitis D Virus/Hepatitis D Virus HDV Recombinant Hepatitis D Virus CB μg CB μg CB μg.1
8 Hepatitis E Virus/Hepatitis E Virus HEV ORF2/ Recombinant Hepatitis E Virus Mosaic-S ORF2/ORF3 33 kda CB μg ORF3 CB μg CB μg HEV ORF2/ Recombinant Hepatitis E Virus Mosaic ORF2/ORF kda CB μg ORF3 CB μg CB μg HEV ORF2 Recombinant Hepatitis E Virus ORF2 (33-59) CB μg CB μg CB μg HEV ORF2 Recombinant Hepatitis E Virus ORF2 (403-41) CB μg CB μg CB μg HEV ORF2 Recombinant Hepatitis E Virus ORF2 (452-17) CB μg CB μg CB μg HEV ORF3 Recombinant Hepatitis E Virus ORF3 CB μg CB μg CB μg Hepatitis B Surface Antigens/Hepatitis B Flächenantigene HBsAg ayw Recombinant Hepatitis B Surface Antigen ayw subtype, CB μg Saccharomyces CB μg CB mg HbsAg ayw Recombinant Hepatitis B Surface Antigen ayw subtype, pichia CB μg Pichia CB μg CB mg HbsAg adr Recombinant Hepatitis B Surface Antigen adr subtype, CB μg Saccharomyces CB μg CB mg HbsAg adr CHO Recombinant Hepatitis B Surface Antigen adr subtype, CHO CB μg CB μg CB mg HbsAg adw Recombinant Hepatitis B Surface Antigen Adw subtype CB μg CB μg CB mg HbsAg pres1 Recombinant Hepatitis B Surface Antigen pres1 CB μg CB μg CB mg HbsAg pres2 Recombinant Hepatitis B Surface Antigen pres2 CB μg CB μg CB mg.2
9 Cytomegalo Virus/Zytomegalo Virus CMV gb Recombinant Cytomegalo Virus gb CB μg CB μg CB μg CMV Pp28 Recombinant Cytomegalo Virus pp28 (UL99) CB μg CB μg CB μg CMV Pp38 Recombinant Cytomegalo Virus Pp38 (UL80a) CB μg CB μg CB μg CMV Pp52 Recombinant Cytomegalo Virus pp52 (UL44) CB μg CB μg CB μg CMV Pp5 Recombinant Cytomegalo Virus pp5 (UL83) CB μg CB μg CB μg CMV Pp150 Recombinant Cytomegalo Virus pp150 (UL32) CB μg CB μg CB μg CMV Mosaic Recombinant Cytomegalo Virus Mosaic CB μg CB μg CB μg Varizella Zoster Virus/Varizella Zoster Virus VZV ge Recombinant Varicella Zoster Virus ge CB μg CB μg CB μg VZV ORF9 Recombinant Varicella Zoster Virus ORF9 CB μg CB μg CB μg VZV ORF2 Recombinant Varicella Zoster Virus ORF2 CB μg CB μg CB μg Toxoplasma Gondii Proteins/Toxoplasma Gondii Proteine Toxoplasma Recombinant Toxoplasma Gondii MIC3 CB μg MIC3 CB μg CB μg Toxoplasma Recombinant Toxoplasma Gondii P24 (GRA 1) CB μg P24 CB μg CB μg Toxoplasma Recombinant Toxoplasma Gondii P29 (GRA 7) CB μg P29 CB μg CB μg Toxoplasma Recombinant Toxoplasma Gondii P30 (SAG 1) CB μg P30 CB μg CB μg Toxoplasma Recombinant Toxoplasma Gondii ROP4 RH2 CB μg ROP4 RH2 CB μg CB μg.3
10 Treponema Pallidum Proteins/Treponema Pallidum Proteine Treponema Recombinant Treponema pallidum p15 (partial) CB μg p15 CB μg CB μg Treponema Recombinant Treponema pallidum p15 CB μg p15 CB μg CB μg Treponema Recombinant Treponema pallidum p15 (Partial), His Tag CB μg p15 His CB μg CB μg Treponema Recombinant Treponema pallidum p17 (Partial) CB μg p17 CB μg CB μg Treponema Recombinant Treponema pallidum p17 CB μg p17 CB μg CB μg Treponema Recombinant Treponema pallidum p41 CB μg p41 CB μg CB μg Treponema Recombinant Treponema pallidum p41 Mosaic CB μg p41 Mosaic CB μg CB μg Treponema Recombinant Treponema pallidum p47 (partial) CB μg p47 CB μg CB μg Treponema Recombinant Treponema pallidum p47 CB μg p47 CB μg CB μg Treponema Recombinant Treponema pallidum TmpA (partial) CB μg TmpA CB μg CB μg Treponema Recombinant Treponema pallidum TmpA CB μg TmpA CB μg CB μg 4.4
11 HIV/HIV HIV-1Envelope Recombinant HIV-1 Envelope (233) CB μg CB μg CB μg HIV-1 Envelope Recombinant HIV-1 Envelope (288) CB μg CB μg CB μg HIV-1 env- His Recombinant HIV-1 Envelope, His Tag CB μg CB μg CB μg HIV-1 nef Recombinant HIV-1 nef CB μg CB μg CB μg HIV-1 p24c Recombinant HIV-1 p24 Core CB μg CB μg CB μg HIV-1 p24c Sf9 Recombinant HIV-1 p24 Core, Sf9 CB μg CB μg CB μg HIV-1 p24 Recombinant HIV-1 p24 CB μg CB μg CB μg HIV-1 p24 Recombinant HIV-1 p24 gag, His Tag CB μg gag His CB μg CB μg rhiv-1 p24 Recombinant HIV-1 p24, Biotin Labeled CB μg Biotin CB μg CB μg HIV-1 24 HRP Recombinant HIV-1 p24, Horseradish Peroxidase Labeled CB μg CB μg CB μg HIV-1 p24 gag Recombinant HIV-I p24 gag CB μg CB μg CB μg HIV-1 gp41 Recombinant HIV-1 gp41 CB μg CB μg CB μg HIV-1 gp41 His Recombinant HIV-1 gp41, His tag CB μg CB μg CB μg HIV-1 gp41 Recombinant HIV-1 gp41, MBP tag CB μg MBP CB μg CB μg HIV-1 gp41 Recombinant HIV-1 gp41, Biotin Labeled CB μg Biotin CB μg CB μg HIV-1 gp41 Recombinant HIV-1 gp41, Horseradish Peroxidase Labeled CB μg HRP CB μg CB μg HIV-1 gp41 Recombinant HIV-1 gp41 Long ( a.a.) CB μg Long CB μg CB μg HIV-1 gp41 Recombinant HIV-1 gp41 Long, Biotin Labeled CB μg L-Biotin CB μg CB μg HIV-1 gp41 Recombinant HIV-1 gp41 Long, Horseradish peroxidase Labeled CB μg L-HRP CB μg CB μg.5
12 HIV/HIV HIV-1 p55 gag Recombinant HIV-1 p55 gag CB μg CB μg CB μg HIV-1 p pol Recombinant HIV-1 p pol CB μg CB μg CB μg HIV-1 gp120 Recombinant HIV-1 gp120 nef Mosaic CB μg CB μg CB μg HIV-1 gp120 Recombinant HIV-1 gp120 LAV CB μg LAV CB μg CB μg HIV-1 gp120 Recombinant HIV-1 gp120 MN CB μg MN CB μg CB μg HIV-1 gp120 Recombinant HIV-1 gp120 CM CB μg CM CB μg CB μg HIV-1 gp10 Recombinant HIV-1 gp10 LAV CB μg LAV CB μg CB μg HIV-1 gp10 Recombinant HIV-1 gp10 MN CB μg MN CB μg CB μg HIV-1 p17/24 Recombinant HIV-1 gag p17, p24 CB μg CB μg CB μg HIV-1 p17/24/ Recombinant HIV-1 gag p17, p24, gp120 CB μg 120 CB μg CB μg HIV-1 p17-24, Recombinant HIV-1 gag p17-p24, gp41-gp120 CB μg CB μg CB μg HIV-1 Recombinant HIV-1 pol Integrase CB μg Integrase CB μg CB μg HIV-1 Integrase Recombinant HIV-1 p31 Integrase CB μg CB μg CB μg HIV-1 TAT Recombinant HIV-1 TAT CB μg CB μg CB μg HIV-1 TAT Recombinant HIV-1 TAT Clade-C CB μg Clade-C CB μg CB μg HIV-1 TAT Recombinant HIV-1 TAT, Biotin Labeled CB μg Biotin CB μg CB μg HIV-1,2 Recombinant HIV-1 Envelope conjugated to HIV-2 gp39 CB μg CB μg CB μg HIV Type-O Recombinant HIV Type-O Envelope CB μg Envelope CB μg CB μg HIV Type-O Recombinant HIV Type-O gp41 CB μg gp41 CB μg CB μg 4.
13 HIV/HIV HIV Type-O Recombinant HIV Type-O gp41, MBP tag CB μg gp41 MBP CB μg CB μg HIV-2 gp32 Recombinant HIV-2 gp32 CB μg CB μg CB μg HIV-2 gp32 Recombinant HIV-2 gp32, Biotin Labeled CB μg Biotin CB μg CB μg HIV-2 gp32 Recombinant HIV-2 gp32, Horseradish Peroxidase Labled CB μg HRP CB μg CB μg HIV-2 gp3 Recombinant HIV-2 gp3 CB μg CB μg CB μg HIV-2 gp3 Recombinant HIV-2 gp3, MBP tag CB μg MBP CB μg CB μg HIV-2 gp3 His Recombinant HIV-2 gp3, His Tag CB μg CB μg CB μg HIV-2 gp3 Recombinant HIV-2 gp3 ( ) CB μg ( ) CB μg CB μg HIV-2 Envelope Recombinant HIV-2 Envelope CB μg CB μg CB μg SIV p55 Recombinant SIV p55 CB μg CB μg CB μg Human L-Lymphotropic Virus/Humaner L-Lymphotropenvirus HTLV-1 Recombinant HTLV-1 Envelope CB μg Envelope CB μg CB μg HTLV-1 p24c Recombinant HTLV-1 p24 Core CB μg CB μg CB μg HTLV-1 gp21 Recombinant HTLV-1 gp21 CB μg CB μg CB μg HTLV-1 gp4 Recombinant HTLV-1 gp4 CB μg CB μg CB μg HTLV-1 Mosaic Recombinant HTLV-1 Mosaic CB μg CB μg CB μg HTLV 1+2 Recombinant HTLV 1+2 CB μg CB μg CB mg.7
14 Epstein Barr Virus/Epstein Barr Virus EBV EBNA1 Recombinant Epstein-Barr Virus (HHV-4) Mosaic EBNA1 CB μg CB μg CB μg EBV EA Recombinant Epstein-Barr Virus (HHV-4) Early Antigen CB μg CB μg CB μg EBV p18 Recombinant Epstein-Barr Virus (HHV-4) p18 CB μg CB μg CB μg EBV Mosaic Recombinant Epstein-Barr Virus (HHV-4) Mosaic p18 CB μg CB μg CB μg EBV p23 Recombinant Epstein-Barr Virus (HHV-4) p23 CB μg CB μg CB μg Encephalitis Virus/Enzephalitis Virus Encephalitis ge Recombinant Tick-Borne Encephalitis Virus ge CB μg CB μg CB μg Encephalitis Recombinant Tick-Borne Encephalitis Virus NE/gE CB μg NE/gE CB μg CB μg Encephalitis Recombinant Tick-Borne Encephalitis Virus CE/gE CB μg CE/gE CB μg CB μg Encephalitis Recombinant Tick-Borne Encephalitis Virus NE/GE/CE/gE CB μg NE/GE/CE/gE CB μg CB μg Encephalitis Recombinant Tick-Borne Encephalitis Virus ge middle (50-250) CB μg ge middle CB μg CB μg Encephaliti Recombinant Tick-Borne Encephalitis Virus ge C-end (29-414) CB μg sc-end CB μg CB μg Encephalitis Recombinant Japanese Encephalitis Virus CB μg Japanese CB μg CB μg Encephalitis Recombinant Tick-Borne Encephalitis Virus Core CB μg Core CB μg CB μg Encephalitis Recombinant Tick-Borne Encephalitis Virus NS3 CB μg NS3 CB μg CB μg Encephalitis Recombinant Tick-Borne Encephalitis Virus prem CB μg PreM CB μg CB μg 4.8
15 Measles Virus/Masern Virus Measles Recombinant Measles Virus Large Polymerase (58-149) CB μg Polymerase CB μg CB μg Measles (1-51) Recombinant Measles Virus Non-Structural C-Protein (1-51) CB μg CB μg CB μg Measles Recombinant Measles Virus Large Polymerase ( ) CB μg Polymerase CB μg CB μg Measles Recombinant Measles Virus Nucleocapsid CB μg Nucleocapsid CB μg CB μg Measles Recombinant Measles Virus Hemagglutinin Mosaic CB μg Mosaic (1-30, , ) CB μg CB μg Measles Recombinant Measles Virus ( ) CB μg ( ) CB μg CB μg Measles Recombinant Measles Virus Fusion Mosaic (10-114, ) CB μg Mosaic CB μg CB μg Rubella Virus/Röteln Virus Rubella Mosaic Recombinant Rubella Virus E1 Mosaic CB μg CB μg CB μg Rubella E2 Recombinant Rubella Virus E2 CB μg CB μg CB μg Rubella Capsid Recombinant Rubella Virus Capsid C CB μg CB μg CB μg.9
16 Influenza Virus/Grippe Virus Caledonia Recombinant Hemagglutinin-Influenza A Virus H1N1 CB μg 20/99 New Caledonia 20/99 CB μg CB μg Texas 3/91 Recombinant Hemagglutinin-Influenza A Virus H1N1 Texas 3/91 CB μg CB μg CB μg Netherlands Recombinant Hemagglutinin-Influenza A Virus H7N7 CB μg 219/03 Netherlands 219/03 CB μg CB μg Vietnam Recombinant Hemagglutinin-Influenza A Virus H5N1 CB μg 1203/04 Vietnam 1203/04 CB μg CB μg New York Recombinant Hemagglutinin-Influenza A Virus H3N2 CB μg 55/04 New York 55/04 CB μg CB μg Wyoming 3/03 Recombinant Hemagglutinin-Influenza A Virus H3N2 CB μg Wyoming 3/03 CB μg CB μg Wisconsin Recombinant Hemagglutinin-Influenza A Virus H3N2 CB μg 7/05 Wisconsin 7/05 CB μg CB μg Hong Kong Recombinant Hemagglutinin-Influenza A Virus H9N2 CB μg 1073/99 Hong Kong 1073/99 CB μg CB μg Hong Kong Recombinant Hemagglutinin-Influenza B Virus Hong Kong 330/01 CB μg 330/01 CB μg CB μg Ohio 01/05 Recombinant Hemagglutinin-Influenza B Virus Ohio 01/05 CB μg CB μg CB μg Jilin 20/03 Recombinant Hemagglutinin-Influenza B Virus Jilin 20/03 CB μg CB μg CB μg Qingdao Influenza B Virus Qingdao 102/91 CB μg 102/91 CB μg CB mg Tokio 53/99 Influenza B Virus Tokio 53/99 CB μg CB μg CB mg Victoria Influenza B Virus Victoria 504/00 CB μg 504/00 CB μg CB mg Beijing 22/95 Influenza A Virus (H1N1) Beijing 22/95 CB μg CB μg CB mg Caledonia Influenza A Virus (H1N1) New Caledonia 20/99 IV 11 CB μg 20/99 CB μg CB mg Shangdong Influenza A Virus (H3N2) Shangdong 9/93 CB μg 9/93 CB μg CB mg Kiev 301/94 Influenza A Virus (H3N2) Kiev 301/94 like/johannesburg 33/94 CB μg CB μg CB mg Panama Influenza A Virus (H3N2) Panama 2007/99 CB μg 2007/99 CB μg CB mg Taiwan 1/8 Influenza A Virus (H1N1) Taiwan 1/8 CB μg CB μg CB mg 4.70
17 West-Nile Virus/West-Nil Virus WNV Envelope Recombinant West Nile Envelope Virus CB μg CB μg CB μg WNV Pre-M Recombinant West Nile Pre-M Virus CB μg CB μg CB μg Dengue Virus/Dengue Virus Dengue NS3 Recombinant Dengue Virus NS3 Type 1 CB μg CB μg CB μg Dengue NS1c Recombinant Dengue Virus NS1 c-end Type 2 CB μg CB μg CB μg Dengue NS1n Recombinant Dengue Virus NS1 n-end Type 2 CB μg CB μg CB μg.71
ViroGen Catalog. Table of contents
Table of contents 1 About... 3 1.1 ABOUT THE COMPANY...3 1.2 ViroGen News...3 1.3 Contact ViroGen...3 2 Services...4 2.1 Services...4 3 Products... 4 3.1 Categories... 4 3.2 Blood Group Antibodies... 5
Infectious Disease Antibodies and Antigens. ...Viro Stat. Supplying Researchers and Manufacturers Since 1985. www.virostat-inc.com
Infectious Disease Antibodies and Antigens...Viro Stat Supplying Researchers and Manufacturers Since 1985 Infectious Disease Antibodies and Antigens...Viro Stat Supplying Researchers and Manufacturers
NEWSLETTER October 2013. From Research to Discovery. Virology. Virology-related antibodies from CovalAb. Created by CovalAb All rights reserved
NEWSLETTER October 2013 From Research to Discovery Virology Virology-related antibodies from CovalAb Created by CovalAb All rights reserved www.covalab.com CovalAb 11 avenue Albert Einstein 69100 VILLEURBANNE
Where Convenience Begins. BEP 2000 Advance System. Answers for life.
Where Convenience Begins BEP 2000 Advance System Answers for life. BEP 2000 Advance System The BEP 2000 Advance System meets the demands for a high level of automation in this millenium. The requirements
The Regional Virus Laboratory is the only CPA accredited provider of virology services in N. Ireland.
Regional Virus Laboratory The Regional Virus Laboratory is the only CPA accredited provider of virology services in N. Ireland. The full postal address is: Regional Virus Laboratory Kelvin Building Royal
Infectious Disease Markers (IDMs) Data
Instructions for Infectious Disease Markers Form (Form 2004 Revision 4) This section of the CIBMTR Forms Instruction Manual is intended to be a resource for completing the Infectious Disease Markers Form.
INNOVATIVE SOLUTIONS. TRUSTED PARTNER.
INNOVATIVE SOLUTIONS. TRUSTED PARTNER. Meridian Life Science, Inc., through our four brands: BIODESIGN International, OEM Concepts, Viral Antigens and Meridian Biologics, is a leading supplier and manufacturer
About Our Products. Blood Products. Purified Infectious/Inactivated Agents. Native & Recombinant Viral Proteins. DNA Controls and Primers for PCR
About Our Products Purified Infectious/Inactivated Agents ABI produces a variety of specialized reagents, allowing researchers to choose the best preparations for their studies. Available reagents include
Recombinant protein vaccines produced in insect cells
Recombinant protein vaccines produced in insect cells Manon M.J. Cox Hong Kong 25JAN2013 Flublok BREAKING NEWS 16JAN2013 FDA approves Flublok for the prevention of influenza in adults 18-49 years old The
Biokit, S.A. was founded in 1973 with entirely private capital. Its purpose is the research, development, production and distribution of clinical
Biokit, S.A. was founded in 1973 with entirely private capital. Its purpose is the research, development, production and distribution of clinical diagnostic reagents. Biokit belongs to an international
Microbiology Specimen Collection Instructions. Alphabetical List of Microbiology Tests
Page 1 of 8 Alphabetical List of Tests Test/Specimen Type Collection Table Referred out Abscess aspirate, wound Acanthamoebae Parasitology Acinetobactor screening Adenovirus Serology AFB Stain only Amoebiasis
AIR FORCE REPORTABLE EVENTS GUIDELINES & CASE DEFINITIONS
AIR FORCE REPORTABLE EVENTS GUIDELINES & CASE DEFINITIONS An Air Force addendum to the TRI-SERVICE REPORTABLE EVENTS GUIDELINES & CASE DEFINITIONS Prepared by: Air Force Institute for Operational Health
Meridian Healthcare. medical diagnostics & equipment. Professional Product List 2013
Meridian Healthcare medical diagnostics & equipment Professional Product List 2013 IFA Test Ready to use reagents no reagent dilution, no reagent preparation (except of washing solution) - IgG/ IgM/ IgA
Company presentation
Company Presentation COMPANY PROFILE Global Leader in IVD for over 40 years Italian multinational company Worldwide Broadest Menu in CLIA immunoassay Listed on the stock market in the FTSE Mid Cap Index
Company Presentation. Product availability mentioned in this presentation are subject to local regulatory approval
Company Presentation 2016 Product availability mentioned in this presentation are subject to local regulatory approval What makes DiaSorin a partner of choice Constant Innovation Dedicated to content System
Bureau of Laboratory Quality Standards Page 1 of 6
Biomolecular 1. Plasma HIV (RNA) Reverse Transcriptase PCR 2. Plasma HIV Viral Load (RNA) 3. Plasma HIV-1 Drug Resistance (RNA) - Reverse Transcriptase PCR - Sequencing 2 Genes (Protease 4. and Body Fluid
Virology User Manual
Title: Virology User Manual Code: VIR-MM-UserManual Version: Authors: Authorised By: Authorised At Date: Review On Date: Location Of Copy: Document Status: Ou Name: 16.0 Bruce Macrae and Eleni Nastouli
Blood Screening Assays. CTS lab locations where assays are performed are indicated by alpha codes D, P, and T.
Blood Screening Assays CTS lab locations where assays are performed are indicated by alpha codes D, P, and T. D= performed in Dallas lab FEI: 3002580251 P= performed in Phoenix lab FEI: 3000204058 T= performed
Viral meningitis is a central nervous system (CNS) infection characterized
Viral Meningitis Virginia A. Triant, MD, MPH Viral meningitis is a central nervous system (CNS) infection characterized by signs and symptoms of meningeal inflammation in the absence of positive bacterial
Custom Antibodies Services. GeneCust Europe. GeneCust Europe
GeneCust Europe Laboratoire de Biotechnologie du Luxembourg S.A. 6 rue Dominique Lang L-3505 Dudelange Luxembourg Tél. : +352 27620411 Fax : +352 27620412 Email : info@genecust.com Web : www.genecust.com
Dr. Abonyi Margit PhD SE 1st Medical Clinic Associate Professor. Hepatology-2014
Dr. Abonyi Margit PhD SE 1st Medical Clinic Associate Professor Hepatology-2014 Other virus hepatitis Epstein-Barr vírus Cytomegalo vírus Herpes simplex vírus Coxsackie vírus Hepatitis B vírus Hepadnavírus,
Epstein Barr Virus (EBV) Serological Diagnosis of Epstein Barr Virus. Epstein Barr Virus (EBV) Epstein Barr Virus (EBV)
Serological Diagnosis of Epstein Barr Virus L Ross Whybin SEALS Serology Epstein Barr Virus () Family Herpesviridiae,, subfamily gammaherpesvirinae,, genus lymphocryptovirus ds DNA enveloped virus Nucleocapsid
Determining Donor Eligibility Blood Donor vs. Stem Cell Donor. Wanda Koetz, RN, HPC Clinical Nurse Lead, Memorial Blood Centers ASFA - May 7, 2015
Determining Donor Eligibility Blood Donor vs. Stem Cell Donor Wanda Koetz, RN, HPC Clinical Nurse Lead, Memorial Blood Centers ASFA - May 7, 2015 Objectives The learner will be able to: Define donor eligibility
Bioinformatik virologiska aspekter. Viral genetisk variabilitet! Today!
Bioinformatik virologiska aspekter Magnus Lindh Klinisk virologi Viral genetisk variabilitet! ü Methods!! ü Phylogeny! Tracing source, evolution! ü Mutationer! Resistance!!! ü Genotyper! Pathogenesis!
Multiplex PCR: Optimization and Application in Diagnostic Virology
Multiplex PCR: Optimization and Application in Diagnostic Virology Elfath M. Elnifro, Ahmed M. Ashshi, Robert J. Cooper and Paul E. Klapper Clin. Microbiol. Rev. 2000, 13(4):559. DOI: 10.1128/CMR.13.4.559-570.2000.
Anti-HCV II Antibody to hepatitis C virus (anti-hcv)
REF 06368921 190 100 English Intended use Anti-H II is an in vitro diagnostic test for the qualitative detection of antibodies to hepatitis C virus (H) in human serum and plasma. This assay is indicated
Tissues and Cells: MSM* Donor Selection Review
Tissues and Cells: MSM* Donor Selection Review July 2013 *MSM men who have had sex with men Page 1 of 149 Table of Contents 1. Executive summary... 7 1.1. Background... 7 1.2. Methodology... 7 1.3. Recommendations
Prevention of opportunistic infections in patients with inflammatory bowel disease. JF Rahier UCL Mont Godinne
Prevention of opportunistic infections in patients with inflammatory bowel disease JF Rahier UCL Mont Godinne Société Royale Belge de Gastro entérologie 13 juin 2009 OI: definition An opportunistic infection
Viral Safety of Plasma-Derived Products
Viral Safety of Plasma-Derived Products SLIDE 1 This presentation will cover viral validation studies for plasma-derived products. FDA requires that the manufacturing process for biopharmaceutical products
VIRAL ENCEPHALITIS: CAUSES, DIFFERENTIAL DIAGNOSIS, AND MANAGEMENT
i10 VIRAL ENCEPHALITIS: CAUSES, DIFFERENTIAL DIAGNOSIS, AND MANAGEMENT P G E Kennedy E J Neurol Neurosurg Psychiatry 2004; 75(Suppl I):i10 i15. doi: 10.1136/jnnp.2003.034280 ncephalitis refers to an acute,
Viral Replication. Viral Replication: Basic Concepts
Viral Replication Scott M. Hammer, M.D. Viral Replication: Basic Concepts Viruses are obligate intracellular parasites Viruses carry their genome (RNA or DNA) and sometimes functional proteins required
Human Immunodeficiency Virus Acquired Immunodeficiency syndrome first described in 1981 HIV-1 isolated in 1984, and HIV-2 in 1986 Belong to the lentiv
Global HIV/AIDS Manju Gaglani, M. D. Pediatric Infectious Diseases Scott & White Clinic Human Immunodeficiency Virus Acquired Immunodeficiency syndrome first described in 1981 HIV-1 isolated in 1984, and
Vaccine Development for Developing Countries Regulatory Approach in the European Union
Vaccine Development for Developing Countries Regulatory Approach in the European Union Dr. Manfred G. Haase, Langen, Germany ECI Vaccine Technology II, June 1-6, 2008, Albufeira, Portugal 1 Regulation
Identification of Tick-Borne Encephalitis Virus CD4+ and CD8+ T-Cell Epitopes in Vaccinated or Naturally Infected Humans
Identification of Tick-Borne Encephalitis Virus CD4+ and CD8+ T-Cell Epitopes in Vaccinated or Naturally Infected Humans Schwaiger Julia Clinical Institute of Virology 29.06.2009 1 Thank you! Franz X.
OraQuick HCV Rapid Antibody Test Customer Letter
OraQuick HCV Rapid Antibody Test Customer Letter Dear Customer, Thank you for deciding to use the OraQuick HCV Rapid Antibody Test. The sale, distribution, and use of this product is restricted as described
Committed to innovation and growth
Committed to innovation and growth Roland Diggelmann, COO Roche Diagnostics Bad Ragaz, 16 Jan 2015 Business model & strategy Q3 2014 overview Major products, launches and newsflow Building a leading sequencing
Viruses. Viral components: Capsid. Chapter 10: Viruses. Viral components: Nucleic Acid. Viral components: Envelope
Viruses Chapter 10: Viruses Lecture Exam #3 Wednesday, November 22 nd (This lecture WILL be on Exam #3) Dr. Amy Rogers Office Hours: MW 9-10 AM Too small to see with a light microscope Visible with electron
Liaquat University of Medical & Health Sciences, Jamshoro
Liaquat University of Medical & Health Sciences, Jamshoro S.NO NAME OF EQUIPMENT STATUS PARTICULARS OF TESTS RATES PER TEST (RS.) 1 DNA-Sequencer Functional DNA Sequencing Reaction (Unidirectional) 360
BLOOD DONOR TESTING & LOOKBACK STUDIES Shan Yuan, MD Last Updated 2/8/2011. 1. ABO Typing: Performed each time with each donation
Testing Performed: BLOOD DONOR TESTING & LOOKBACK STUDIES Shan Yuan, MD Last Updated 2/8/2011 1. ABO Typing: Performed each time with each donation 2. Rh Typing: o Performed along with ABO typing to determine
Premarital Screening Standard. Premarital Screening and Counseling Program. Version 1.1
Premarital Screening Standard Premarital Screening and Counseling Program Version 1.1 July 2013 Table of Contents Page Table of Contents 1 Table of Appendixes 2 Abbreviation list 3 Introduction 4 PS.1
What is the problem? CMV in pregnancy - how much testing is enough. Babies are such a nice way to. Bill Rawlinson
in pregnancy - how much testing is enough Babies are such a nice way to start people. ~Don Herrold Bill Rawlinson w.rawlinson@unsw.edu.au What is the problem? Congenital (c) is the most common viral cause
Donating bone marrow or peripheral blood stem cells Information for the donor family
Donating bone marrow or peripheral blood stem cells Information for the donor family Introduction This information has been written for you as a brother, sister or parent and potential bone marrow or stem
CATALOGUE Equipment and reagents for PCR
tel/fax +7(45) 804555 CATALOGUE Equipment and reagents for PCR valid from 01.04.2014 Content Product definition RealTime PCR Kits for pathogens detection and quantification FLASH PCR Kits (end-point fluorescent
Chapter 6. Antigen-Antibody Properties 10/3/2012. Antigen-Antibody Interactions: Principles and Applications. Precipitin reactions
Chapter 6 Antigen-Antibody Interactions: Principles and Applications Antigen-Antibody Properties You must remember antibody affinity (single) VS avidity (multiple) High affinity: bound tightly and longer!
Aviva Systems Biology
Aviva Custom Antibody Service and Price Mouse Monoclonal Antibody Service Package Number Description Package Contents Time Price Customer provides antigen protein $6,174 Monoclonal package1 (From protein
Maternal and Child Health
Roles of Maternal and Child Health Reproductive health Prenatalcare Screening in infancy, childhood and adolescence Encouragement of breastfeeding Immunization Prevention of childhood diseases Participants:
Molecular Diagnosis of Hepatitis B and Hepatitis D infections
Molecular Diagnosis of Hepatitis B and Hepatitis D infections Acute infection Detection of HBsAg in serum is a fundamental diagnostic marker of HBV infection HBsAg shows a strong correlation with HBV replication
EU Declaration of Conformity
EU Declaration of Conformity Omega Diagnostics Omega House Hillfoots Business Village Alva Scotland United Kingdom FK12 5DQ Manufacturer Identification Code GB / 000072 Medicines and Healthcare Products
Main Changes to the Vaccination Schedule Recommended by the Japan Pediatric Society January 12, 2014
Main Changes to the Vaccination Schedule Recommended by the Japan Pediatric Society January, 04 ) 3-valent Pneumococcal conjugate vaccine (PCV3) The description of catch-up schedule for PCV3 has been revised
NovaLisa (ZVM0790) Performance Characteristics
NovaLisa Zika Virus IgM µ-capture ELISA (ZVM0790) Performance Characteristics Table of Contents 1 Introduction... 3 2 Intended Use... 4 3 Principle of the Assay... 4 4 Performance Characteristics... 4
Supplementary Online Content
Supplementary Online Content Huang H, Li X, Zhu J, et al. Entecavir vs lamivudine for prevention of hepatitis B virus reactivation among patients with untreated diffuse large B-cell lymphoma receiving
TOWARDS AN HIV VACCINE
why is it so hard to make an HIV vaccine and where are we now? Neal Nathanson, MD Emeritus Professor Department of Microbiology University of Pennsylvania School of Medicine 1 Estimated number of persons
Administrative Code. Title 23: Medicaid Part 224 Immunizations
Administrative Code Title 23: Medicaid Part 224 Immunizations Table of Contents Title 23: Division of Medicaid... 1 Part 224: Immunizations... 1 Part 224 Chapter 1: General... 1 Rule 1.1: Reserved... 1
NEWER VACCINES IN THE PIPELINE
Section 14 Immunology 101 Chapter Adult Immunization Asha N Shah INTRODUCTION There is a common consensus among public health managers that disease prevention is the most cost-effective option to protect
INTERPRETATION INFORMATION SHEET
Creative Testing Solutions 2424 West Erie Dr. 2205 Highway 121 10100 Martin Luther King Jr. St. No. Tempe, AZ 85282 Bedford, TX 76021 St. Petersburg, FL 33716 INTERPRETATION INFORMATION SHEET Human Immunodeficiency
The immunogenic vaccine against HCV and HBV
National Centre for Research and Development, The immunogenic vaccine against HCV and HBV Katarzyna Grzyb Laboratory of Virus Molecular Biology Intercollegate Faculty of Biotechnology UG-MUG 1 Hepatitis
Legacy WEBLink Test Updates
ACANT ACANTHAMOEBA AND NAEGLERIA CULTURE from ACANTHAMOEBA CULTURE to ACANTHAMOEBA AND NAEGLERIA CULTURE ACANTSTAIN AMOEBA CALCOFLUOR STAIN from ACANTHAMOEBA STAIN to AMOEBA CALCOFLUOR STAIN ALLALD ALLERGEN
Effective Treatment of Lyme Borreliosis with Pentacyclic Alkaloid Uncaria tomentosa (TOA-free Cat s Claw)
Effective Treatment of Lyme Borreliosis with Pentacyclic Alkaloid Uncaria tomentosa (TOA-free Cat s Claw) Executive Summary Introduction In a six-month prospective cohort study designed to compare the
CatalogNo Product Name Size
SIG-3250-1000 α-1-antichymotrypsin Polyclonal Antibody, Purified (SIGNET) SIG-3250-16 α-1-antichymotrypsin Polyclonal Antibody, Purified (SIGNET) L1 6mL SIG-3250-26 α-1-antichymotrypsin Polyclonal Antibody,
Breakthroughs and Big Questions: AIDS vaccine research in 2014
Breakthroughs and Big Questions: AIDS vaccine research in 2014 Mary A. Marovich Director, Vaccine Research Program Division of AIDS NIAID/NIH May 19, 2014 1 Future of HIV-1 vaccines is bright Major breakthroughs
Really Good Antibodies. Secondary Antibodies. Over 670 Anti-Mouse, Rabbit, Goat and Rat Secondary Antibodies. bethyl.com
Really Good Antibodies Secondary Antibodies Over 670 Anti-Mouse, Rabbit, Goat and Rat Secondary Antibodies bethyl.com Bethyl Laboratories, Inc. has been dedicated to supporting scientific discovery through
Rapid Screening Tests
Rapid Screening Tests Infectious Diseases Cardiac Marker Tumor Markers Pregnancy Rheumatology Allergy Drugs of Abuse > For rapid and cost-effective diagnosis > Accurate, reliable results > Easy to use
Annex to the Accreditation Certificate D-ML-13455-01-00 according to DIN EN ISO 15189:2014
Deutsche Akkreditierungsstelle GmbH German Accreditation Body Annex to the Accreditation Certificate D-ML-13455-01-00 according to DIN EN ISO 15189:2014 Period of validity: 22.04.2015 to 25.09.2018 Date
REF 11662988122, ProCell, 6 x 380 ml system buffer REF 11662970122, CleanCell, 6 x 380 ml measuring cell cleaning solution
REF 05390095 119 100 English Intended use Immunoassay for the in vitro qualitative determination of HIV-1 p24 antigen and antibodies to HIV-1, including group O, and HIV-2 in human serum and plasma. This
AccuDiag HCV Ab ELISA
AccuDiag HCV Ab ELISA Cat# 1707- See external Label 9 Tests IgG ANTIBODIES TO HEPATITIS C VIRUS ELISA KIT Two-Step Incubation, Indirect Principle Test HCV Ab ELISA Method Enzyme Linked Immunosorbent Assay
Table of Contents. 25.2.2.1 Engineering and Work Practice Controls. 25.2.3 Departments Who Provide Services to Patients
Table of Contents 25 Chapter 25 Aerosol Transmissible Diseases 25.1 Foreword 25.2 Introduction 25.2.1 Referring Departments 25.2.1.1 Typical Referring Departments 25.2.1.2 Infection Control Procedures
Guide to Completing the Perinatal Record Perinatal Worksheet1
Guide to Completing the Perinatal Record Perinatal Worksheet1 Ohio Department of Health 1 Revised 5.18.07 1 Table of Contents Perinatal Worksheet... 4 Date of Encounter... 4 Site Letter... 4 Home Visit...
Blood Donor Eligibility. Shan Yuan, MD October 5 th, 2010
Blood Donor Eligibility Shan Yuan, MD October 5 th, 2010 Question 1 Which of the following blood donors is eligible for allogeneic whole blood donation? A. 88yo F, Hgb=12.5g/dL, weight 116 lbs B. 36 yo
Streptococcus pneumoniae IgG AB (13 Serotypes), MAID... 7
Volume 12 December 2011 Table of Contents Summary of Test Changes... 3 Test Changes... 6 Human Anti-Mouse AB (HAMA), ELISA... 6 Hepatitis E Antibody (IgG, IgM)... 6 Hepatitis E Antibody (IgG)... 6 Hepatitis
POLYMERASE CHAIN REACTION FOR THE LABORATORY DIAGNOSIS OF ASEPTIC MENINGITIS AND ENCEPHALITIS
Arq Neuropsiquiatr 2000;58(3-B):836-842 POLYMERASE CHAIN REACTION FOR THE LABORATORY DIAGNOSIS OF ASEPTIC MENINGITIS AND ENCEPHALITIS MARISA CHESKY*, ROSANA SCALCO*, LUCIANE FAILACE**, STEVEN READ***,
Cleaning and Disinfection Protocol for Enveloped Viruses
This document has been developed in accordance with current applicable infection control and regulatory guidelines. It is intended for use as a guideline only. At no time should this document replace existing
Aviva Systems Biology
Aviva Custom Antibody Services and Prices Rabbit Polyclonal Antibody Service Package Number Description Package Contents Time Price Polyclonal package 1 (From protein to antiserum) Polyclonal package 2
41 Viral rashes and skin infections
41 Viral rashes and skin infections Clinical There are several kinds of skin infections caused by viruses, and these are best considered in the four categories that group together similar symptoms for
Nel 2010, A.S.T. S.r.l. ha deciso di creare una divisione rivolta ad uno specifico settore: A.S.T. Biomedical (Advanced Scientific Technologies).
REAGENTI MEDICAL Microdispensatori per liquidi in provetta e piastre completamente automatizzati. Strumentazione per diagnosi in assorbanza e in chemiluminescenza con tecnologia proprietaria. Micro dispenser
2.0 Rationale, Purpose and Scope... 5. 4.0 Definitions... 6. 5.0 General Principles... 7
Table of Contents Principles of IVD Medical Devices Classification 1.0 Introduction... 4 2.0 Rationale, Purpose and Scope... 5 2.1 Rationale... 5 2.2 Purpose... 5 2.3 Scope... 5 3.0 References... 5 4.0
WEEKLY INFECTIOUS DISEASE BULLETIN EPIDEMIOLOGICAL WEEK 13 29 Mar - 4 Apr 2015
WEEKLY INFECTIOUS DISEASE BULLETIN EPIDEMIOLOGICAL WEEK 9 Mar - Apr VOL. NO. http://www.moh.gov.sg/content/moh_web/home/statistics/infectiousdiseasesstatis tics/weekly_infectiousdiseasesbulletin.html Published
These are illnesses which might not only spoil your holiday but might also pose a risk to your life.
Travel Vaccinations Travel vaccinations are an essential part of holiday and travel planning, particularly if your journey takes you to an exotic destination or 'off the beaten track'. The risks are not
Pennsylvania Hospital & Surgery Center of Pennsylvania Hospital ADMINISTRATIVE POLICY MANUAL
Page 1 Issued: March 1978 Committee Approval: Human Resources Employee Health Infection Control Administrative Policy Review Committee: January 1982 December 1986 June 1989 April 1991 December 1993 March
Viral Hepatitis. 2009 APHL survey report
Issues in Brief: viral hepatitis testing Association of Public Health Laboratories May Viral Hepatitis Testing 9 APHL survey report In order to characterize the role that the nation s public health laboratories
TG1050, A NOVEL IMMUNOTHERAPEUTIC TO TREAT CHRONIC HEPATITIS B, CAN CONTROL HBsAg AND PROVOKE HBsAg SEROCONVERSION IN HBV-PERSISTENT MOUSE MODELS
TG1050, A NOVEL IMMUNOTHERAPEUTIC TO TREAT CHRONIC HEPATITIS B, CAN CONTROL HBsAg AND PROVOKE HBsAg SEROCONVERSION IN HBV-PERSISTENT MOUSE MODELS Karine Lélu 1, Alexei Evlachev 1, Roland Kratzer 1, Sarah
HBV DNA < monitoring interferon Rx
Hepatitis B Virus Suspected acute hepatitis >>Order: Acute Unknown hepatitis screen Suspected chronic hepatitis >>Order: Chronic unknown hepatitis screen Acute HBV or Delayed Anti HBs response after acute
Domain Antivirals tested Test methods for phenotype References. Aciclovir (ACV), Foscarnet (FOS) ACV, FOS ACV,
Sauerbrei A, Bohn-Wippert K, Kaspar M, Krumbholz A, Karrasch M, Zell R. 2015. Database on natural polymorphisms and resistance-related non-synonymous mutations in thymidine kinase and DNA polymerase genes
The Epidemiology of Hepatitis A, B, and C
The Epidemiology of Hepatitis A, B, and C Jamie Berkes M.D. University of Illinois at Chicago jberkes@uic.edu Epidemiology: Definitions The study of the incidence and prevalence of diseases in large populations
STANDARD OPERATING PROCEDURE. (Changes from previous version highlighted) Date of next review Date reviewed Reviewed by Action 05-08-2014
Qpulse5/docs/active/NIC0104v8 1 of 89 STANDARD OPERATING PROCEDURE Title: Document number: Handbook (NICD) NIC0104 Version number: 8 (Changes from previous version highlighted) Written by: Checked by:
Be Healthy. Be Healthy. Using Your Wellness Benefits. Helping You Stay Healthy. Wellness Benefits
Be Healthy Wellness Benefits Be Healthy Using Your Wellness Benefits Helping You Stay Healthy Health Alliance emphasizes prevention through comprehensive wellness coverage. We support members throughout
PARENTS PERSONAL INFORMATION
MOTHER S CONTACT INFORMATION PARENTS PERSONAL INFORMATION (Legal) First Name Middle Name Last Name Mailing address: City: State: Country: Zip: Telephone: Home: Email address: Mother s birth date: Cell:
Regulations of Connecticut State Agencies. R.C.S.A. 10-204a-1 10-204a-4 CONTENTS. Procedures for reporting immunization data
Agency Subject School Immunizations Requirements Inclusive Sections 10-204a-1 10-204a-4 Sec. 10-204a-1. Sec. 10-204a-2. Sec. 10-204a-2a. Sec. 10-204a-3. Sec. 10-204a-3a. Sec. 10-204a-4. CONTENTS Definitions
Betting Duty (Amendment) Ordinance 2013. Contents
Betting Duty (Amendment) Ordinance 2013 Betting Duty (Amendment) Ordinance 2013 Contents Ord. No. 6 of 2013 A119 Section Page Part 1 Preliminary 1. Short title and commencement... A123 Amendments to Betting
Guidelines for Vaccinating Pregnant Women
Guidelines for Vaccinating Pregnant Women U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Centers for Disease Control & Prevention Guidelines for Vaccinating Pregnant Women from Recommendations of the Advisory
Procedure Code(s): n/a This counseling service is included in a preventive care wellness examination or focused E&M visit.
Coding Summary for Providers NOTE THE FOLLOWING: The purpose of this document is to provide a quick reference of the applicable codes for UnitedHealthcare plans that cover preventive care services in accordance
Full length genome characterisation of Hepatitis B virus isolates at Dr George Mukhari hospital in Pretoria, South Africa. Rindidzani Edith Magobo
Full length genome characterisation of Hepatitis B virus isolates at Dr George Mukhari hospital in Pretoria, South Africa. By Rindidzani Edith Magobo Submitted in fulfilment of the requirement for the
Travel Vaccine Schedule
Travel Vaccine Schedule This table acts as a quick guide to vaccine schedules. The Summary of Product Characteristics should always be referred to for more detailed information. Vaccine Cholera Dukoral
Regulations for Disease Reporting and Control
Regulations for Disease Reporting and Control Department of Health Commonwealth of Virginia State Board of Health March 2011 Virginia Department of Health Office of Epidemiology 109 Governor Street P.O.
LIAISON XL HCV Ab Accurate diagnosis of the early stage of HCV infection
Hepatitis and Retrovirus LIAISON XL HCV Ab Accurate diagnosis of the early stage of HCV infection FOR OUTSIDE THE US AND CANADA ONLY LIAISON XL HCV Ab is Your solution LIAISON XL murex HCV Ab main features
Background: 1) Does your center have effective ways of collecting data from multiple sources to submit to multiple organizations?
University of Michigan Best Practices Pam James, MS CCRP Administrative Manager, Data Management Bone Marrow Transplant, Hematologic Malignancies & NCCN Background: The data management team at the University
PERINATAL AND CHILDHOOD HEPATITIS.. WHAT ABOUT THE CHILDREN?
PERINATAL AND CHILDHOOD HEPATITIS.. WHAT ABOUT THE CHILDREN? John T. Stutts, MD, MPH University of Louisville School of Medicine Department of Pediatrics Division of Pediatric Gastroenterology, Hepatology
Message from the Director
Message from the Director On behalf of the Public Health Laboratory (PHL), Public Health Branch, I am pleased to submit the 2011-2014 Business Plan to the Minister of the Department of Health and Community
Vaccination (Immunization)
Policy Number IMM10012009SC Approved By Vaccination (Immunization) UnitedHealthcare Medicare Committee Current Approval Date 04/08/2015 IMPORTANT NOTE ABOUT THIS REIMBURSEMENT POLICY This policy is applicable
TRANSGENE SA, FRANCE 2. INSTITUT PASTEUR, FRANCE On behalf. AFEF 2013, Lille 02 nd October 2013
A MULTIVALENT ADENOVIRUS-BASED IMMUNOTHERAPEUTIC FOR TREATMENT OF CHRONIC HEPATITIS B INDUCES BROAD, ROBUST AND POLYFUNCTIONAL T CELLS IN NAIVE MICE AND EXERT AN EARLY ANTIVIRAL EFFECT IN HBV TOLERANT
Appendix B: Provincial Case Definitions for Reportable Diseases
Infectious Diseases Protocol Appendix B: Provincial Case Definitions for Reportable Diseases Disease: Hepatitis B Revised Hepatitis B 1.0 Provincial Reporting Confirmed, chronic and probable cases of disease